当前位置:首页 - 行情中心 - 之江生物(688317) - 财务分析 - 现金流量表

之江生物

(688317)

  

流通市值:44.64亿  总市值:44.64亿
流通股本:1.92亿   总股本:1.92亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金80,671,108.6341,890,096.09214,886,011.55158,023,714.74
  收到的税费返还--3,401,204.06-
  收到其他与经营活动有关的现金43,534,92011,782,623.92120,594,185.4685,645,258.62
  经营活动现金流入小计124,206,028.6353,672,720.01338,881,401.07243,668,973.36
  购买商品、接受劳务支付的现金10,449,478.028,925,158.9344,728,265.8359,820,425.65
  支付给职工以及为职工支付的现金40,242,703.6122,102,122.2297,574,616.2278,188,799.34
  支付的各项税费9,796,6485,473,910.4720,612,608.3916,879,558.98
  支付其他与经营活动有关的现金37,892,891.415,170,486.2198,377,198.5945,853,831.16
  经营活动现金流出小计98,381,721.0351,671,677.83261,292,689.03200,742,615.13
  经营活动产生的现金流量净额25,824,307.62,001,042.1877,588,712.0442,926,358.23
二、投资活动产生的现金流量:
  收回投资收到的现金284,689,173.1546,676,231.4521,592,932.28-
  处置固定资产、无形资产和其他长期资产收回的现金净额0-12,0002,226,460.18
  投资活动现金流入小计284,689,173.1546,676,231.4521,604,932.282,226,460.18
  购建固定资产、无形资产和其他长期资产支付的现金2,974,379.52,399,849.519,485,362.2322,766,316.19
  投资支付的现金597,598,133.5195,399,008.521,535,811.82-
  投资活动现金流出小计600,572,513197,798,85841,021,174.0522,766,316.19
  投资活动产生的现金流量净额-315,883,339.85-151,122,626.55-19,416,241.77-20,539,856.01
三、筹资活动产生的现金流量:
  取得借款收到的现金198,000,00099,000,000--
  筹资活动现金流入平衡项目00--
  筹资活动现金流入小计198,000,00099,000,000--
  分配股利、利润或偿付利息支付的现金875,737.5203,50020,882,808.32-
  支付其他与筹资活动有关的现金182,926,350.1889,214,667.8737,837,578.5536,474,049.2
  筹资活动现金流出小计183,802,087.6889,418,167.8758,720,386.8736,474,049.2
  筹资活动产生的现金流量净额14,197,912.329,581,832.13-58,720,386.87-36,474,049.2
四、汇率变动对现金及现金等价物的影响-2,373,500.83-1,067,681.9514,442,150.56-10,932,424.75
五、现金及现金等价物净增加额-278,234,620.76-140,607,434.1913,894,233.96-25,019,971.73
  加:期初现金及现金等价物余额2,783,176,213.262,783,392,638.522,769,281,979.32,769,495,158.09
  期末现金及现金等价物余额2,504,941,592.52,642,785,204.332,783,176,213.262,744,475,186.36
补充资料:
  净利润-9,850,972.77--127,462,123.71-
  资产减值准备-9,593,246.29-162,849,610.59-
  固定资产和投资性房地产折旧25,541,006.04-65,385,568.02-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧25,541,006.04-65,385,568.02-
  无形资产摊销554,391.84-994,936.7-
  长期待摊费用摊销353,985.22-723,423-
  处置固定资产、无形资产和其他长期资产的损失333,569.04--39,305.59-
  固定资产报废损失--5,982,257.69-
  财务费用4,142,590.48--14,038,898.59-
  投资损失-1,069,991.04--57,120.46-
  递延所得税-2,213,818.1--23,249,337.21-
  其中:递延所得税资产减少-2,213,818.1--22,795,309.22-
    递延所得税负债增加0--454,027.99-
  存货的减少13,423,914.91-36,368,902.3-
  经营性应收项目的减少19,042,589.92-37,313,578.51-
  经营性应付项目的增加-15,779,950.85--81,053,201.04-
  其他--975,359.3-
  不涉及现金收支的投资和筹资活动金额其他项目--424,087.67-
  现金的期末余额2,504,941,592.5-2,783,176,213.26-
  减:现金的期初余额2,783,176,213.26-2,769,281,979.3-
  现金及现金等价物的净增加额-278,234,620.76-13,894,233.96-
公告日期2025-08-292025-04-302025-04-252024-10-30
审计意见(境内)标准无保留意见
TOP↑